Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-01

Clinical Trial Update: Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study [Phase 4]

View source ↗

Summary

Clinical trial update detailing a Phase 4 randomized cross-over pilot study evaluating how sulphonylurea receptor mutations influence responsiveness to gliclazi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gliclazide (gliclazide)

Snippet

Sponsor: Khoo Teck Puat Hospital | Conditions: Diabetes | Phase 4 | Status: COMPLETED